Related Experiment Video

Updated: Aug 14, 2026

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
10:32

Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs

Published on: December 19, 2019

High-mobility-group proteins and cancer--an emerging link

V Wunderlich, M Böttger

    Journal of Cancer Research and Clinical Oncology
    |January 1, 1997
    PubMed

    Insights

    High-mobility-group (HMG) proteins are crucial in cancer development and therapy. These architectural proteins regulate genes, are overexpressed in cancer cells, and aid in gene transfer, highlighting their therapeutic potential.

    Area of Science:

    • Molecular Biology
    • Oncology
    • Biochemistry

    Background:

    • High-mobility-group (HMG) proteins are nonhistone proteins discovered in the early 1970s.
    • These proteins play significant roles in cellular processes, including DNA binding and gene regulation.

    Discussion:

    • HMG proteins are frequently overexpressed in transformed cells, with levels correlating to neoplastic progression.
    • Their function as architectural proteins in organizing transcription factors suggests a critical role in neoplastic transformation.
    • HMG proteins can recognize DNA-cisplatin adducts and facilitate gene transfer, indicating therapeutic potential.

    Key Insights:

    • HMG proteins are key regulators of gene transcription and DNA structure.
    • Overexpression of HMG proteins is linked to cancer development and progression.
    • HMG proteins offer potential as therapeutic targets and delivery systems in cancer treatment.

    Outlook:

    • Further research into HMG protein functions may reveal novel cancer therapies.
    • Targeting HMG proteins could offer new strategies for cancer treatment and gene therapy.
    • Understanding HMG protein roles in DNA repair and gene regulation is vital for cancer research.

    More Related Videos

    Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker07:47

    Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

    Published on: September 15, 2023

    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

    Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

    Published on: June 6, 2025

    Related Concept Videos

    Adaptive Mechanisms in Cancer Cells02:53

    Adaptive Mechanisms in Cancer Cells

    Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
    Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    Cancer Cell Migration through Invadopodia01:35

    Cancer Cell Migration through Invadopodia

    Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However, invadopodia can...
    Small GTPases - Ras and Rho01:24

    Small GTPases - Ras and Rho

    Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
    Three regulatory proteins control their activity:
    Adaptive Mechanisms in Cancer Cells02:53

    Adaptive Mechanisms in Cancer Cells

    Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
    Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...